WEO Media vs Bristol Myers Squibb
Side-by-side comparison of AI visibility scores, market position, and capabilities
Dental marketing agency providing websites, SEO, PPC, and patient communication for dental practices in the US and Canada. Beaverton OR; founded 2009;
About
WEO Media is a Beaverton, Oregon-based dental-specific marketing agency and technology company that provides website design, search engine optimization, pay-per-click advertising, online reputation management, and patient communication tools to dental practices across the United States and Canada. Founded in 2009, WEO Media built its business around the unique marketing needs of independent dental practices and DSO-affiliated offices, which differ significantly from general small business marketing in their emphasis on local search visibility, treatment-specific landing pages, patient reviews, and HIPAA-compliant communication. The company combines managed digital marketing services with proprietary technology tools for patient communication and review generation, offering dental practices a full-service growth marketing partner.\n\nWEO Media's website platform is purpose-built for dental practices, with built-in features for treatment page templates, appointment request forms, before-and-after gallery management, and ADA accessibility compliance. The company's SEO methodology focuses on local search dominance—ensuring that each dental practice ranks prominently for high-intent searches like "dentist near me," "dental implants [city]," and "emergency dentist [neighborhood]"—which drives the majority of new patient acquisition for most dental offices. WEO Media manages Google Business Profiles, local citation building, and online review acquisition campaigns as integrated components of its local SEO service.\n\nWEO Media targets independent dental practices and small group practices that want to outsource their digital marketing to a specialist with deep dental industry knowledge rather than working with a general digital marketing agency that lacks familiarity with dental treatment marketing, HIPAA compliance requirements, and the competitive dynamics of local dental markets. The company competes with ProSites, TNT Dental, and PatientSites in the dental marketing agency space, as well as with in-house marketing capabilities at larger DSOs. WEO Media differentiates on its combination of managed services and proprietary technology and its long track record in the dental market.
Princeton NJ biopharma (NYSE: BMY) at $48.3B 2024 revenue; Eliquis $13.3B, Opdivo $9.2B, Cobenfy schizophrenia launch; $23B acquisitions (Karuna+Mirati+RayzeBio) building next pipeline vs. Pfizer and Merck.
About
Bristol Myers Squibb (BMS) is a Princeton, New Jersey-based global biopharmaceutical company — publicly traded on the New York Stock Exchange (NYSE: BMY) as an S&P 500 Healthcare component — discovering, developing, and delivering innovative medicines for serious diseases including cancer, cardiovascular disease, immunology, and neuroscience through approximately 34,000 employees worldwide. In fiscal year 2024, BMS reported total revenue of $48.3 billion (+7% year-over-year), with its Growth Portfolio generating $22.6 billion (+17%), driven by blockbusters Eliquis ($13.3B anticoagulant), Opdivo ($9.2B immuno-oncology), and Revlimid ($5.8B multiple myeloma). New product revenue surged 77% to $3.6 billion, led by schizophrenia treatment Cobenfy (formerly KarXT), CAR-T therapy Breyanzi, anemia drug Reblozyl, and Opdualag checkpoint inhibitor combination. CEO Dr. Christopher Boerner assumed leadership in November 2023, accelerating BMS's pipeline expansion through three transformative acquisitions in 2024: Karuna Therapeutics ($14B, Cobenfy/KarXT for schizophrenia and Alzheimer's agitation), Mirati Therapeutics ($4.8B, KRAS-targeted oncology), and RayzeBio ($4.1B, radiopharmaceutical cancer therapy).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.